Cardiome Pharma Corp.

Who: Advanz Pharma/Correvio Pharma (formerly Cardiome) What: Advanz will purchase troubled Correvio for an expected $76m in cash, nearly two-thirds of which will be used to pay off Correvio’s outst

The US Food and Drug Administration's Center for Drug Evaluation and Research (CDER) did a major holiday season desk cleaning to close out 2019, giving its blessing to six novel products in the year's

It doesn't appear that European postmarketing data will save Correvio Pharma Corp. 's embattled atrial fibrillation (AFib) drug Brinavess (vernakalant) in the US. The US Food and Drug Administration'

The US Food and Drug Administration's next step in its evaluation of Correvio Pharma Corp. 's atrial fibrillation (AFib) candidate Brinavess (vernakalant) will likely be to decide whether to lift the